AI Verdict
IOSP has stronger fundamentals based on our AI analysis.
IOVA vs IOSP Fundamental Comparison
| Metric | IOVA | IOSP |
|---|---|---|
| Revenue | $263.5M | $1.8B |
| Net Income | $-391.0M | $116.6M |
| Net Margin | -148.4% | 6.6% |
| ROE | -56.0% | 8.8% |
| ROA | -42.8% | 6.4% |
| Current Ratio | 3.20x | 2.79x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-1.09 | $4.67 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IOVA vs IOSP: Frequently Asked Questions
Is IOVA or IOSP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IOSP has stronger fundamentals. IOVA is rated STRONG SELL (92% confidence) while IOSP is rated BUY (72% confidence). This is not investment advice.
How does IOVA compare to IOSP fundamentally?
IOVANCE BIOTHERAPEUTICS, INC. has ROE of -56.0% vs INNOSPEC INC.'s 8.8%. Net margins are -148.4% vs 6.6% respectively.
Which stock pays higher dividends, IOVA or IOSP?
IOVA has a dividend yield of N/A or no dividend while IOSP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IOVA or IOSP for long term?
For long-term investing, consider that IOVA has STRONG SELL rating with 92% confidence, while IOSP has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IOVA vs IOSP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IOVA vs IOSP, the AI consensus favors IOSP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.